Investing in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors
Innovation Endeavors

Scientist - Translational Sciences



San Francisco, CA, USA
Posted on Saturday, May 27, 2023

Why join Freenome?

Freenome is a high-growth biotech company developing tests to detect cancer using a standard blood draw. To do this, Freenome uses a multiomics platform that combines tumor and non-tumor signals with machine learning to find cancer in its earliest, most-treatable stages.

Cancer is relentless. This is why Freenome is building the clinical, economic, and operational evidence to drive cancer screening and save lives. Our first screening test is for colorectal cancer (CRC) and advanced adenomas, and it’s just the beginning.

Founded in 2014, Freenome has ~500 employees and more than $1.1B in funding from key investors, such as the American Cancer Society, Andreessen Horowitz, Anthem Blue Cross, Bain Capital, Colorectal Cancer Alliance, DCVC, Fidelity, Google Ventures, Kaiser Permanente, Novartis, Perceptive Advisors, RA Capital, Roche, Sands Capital, T. Rowe Price, and Verily.

At Freenome, we aim to impact patients by empowering everyone to prevent, detect, and treat their disease. This, together with our high-performing culture of respect and cross-collaboration, is what motivates us to make every day count.

Become a Freenomer

Do you have what it takes to be a Freenomer? A “Freenomer” is a determined, mission-driven, results-oriented employee fueled by the opportunity to change the landscape of cancer and make a positive impact on patients’ lives. Freenomers bring their diverse experience, expertise, and personal perspective to solve problems and push to achieve what’s possible, one breakthrough at a time.

What you’ll do:

  • Lead the experimental design, planning, and execution of NGS and multi-omics studies to identify blood based signatures for cancer detection and therapy response
  • Collaborate closely in the planning and execution of projects with both internal and external cross-functional partners, from areas including molecular and computational biology, medical affairs, commercial, and business development
  • Investigate the biological origin of blood-based biomarkers by performing detailed characterization of cell-free material, tumors, and the immune system
  • Collaborate with the molecular and computational research teams to understand and improve the latest multi-omics capabilities, and to implement them in biomarker research projects
  • Execute research projects to model various biological changes resulting from disease and clearly present results through publications, posters, and whitepapers

Must haves:

  • PhD (or equivalent industry experience) in molecular biology, biochemistry, genetics, cancer biology, immunology, or a related field
  • Proven track record of optimizing and executing NGS and/or multiomics wet-lab workflows, preferably on clinical cohorts with limited sample volume
  • Deep understanding of cancer biology and experience working with publicly available datasets used to interrogate molecular mechanisms (e.g., TCGA)
  • Excellent cross-functional communication and teamwork skills, working with both computational and experimental scientists
  • History of completing scientific projects in translational areas such as oncology and/or immunology
  • Ability to perform basic NGS data analysis to enable experimental iteration independent of external support
  • Ability to clearly and concisely communicate new scientific ideas and results, as demonstrated through presentations and publications

Nice to haves:

  • Experience partnering with pharma in biomarker identification or companion diagnostics development
  • Fluency in a common scientific programming language (e.g., Python or R)
  • Experience working with liquid handling platforms for high-throughput research projects
  • Experience mentoring and training research associates
  • Project leadership with cross-functional partners outside of science (e.g. commercial, regulatory, clinical development)

Benefits and additional information:

The US target range of our base salary for new hires is $115,000 - $175,000. You will also be eligible to receive pre-IPO equity, cash bonuses, and a full range of medical, financial, and other benefits depending on the position offered. Please note that individual total compensation for this position will be determined at the Company’s sole discretion and may vary based on several factors, including but not limited to, location, skill level, years and depth of relevant experience, and education. We invite you to check out our career page @ for additional company information.

Freenome is proud to be an equal-opportunity employer, and we value diversity. Freenome does not discriminate on the basis of race, color, religion, marital status, age, national origin, ancestry, physical or mental disability, medical condition, pregnancy, genetic information, gender, sexual orientation, gender identity or expression, veteran status, or any other status protected under federal, state, or local law.

Applicants have rights under Federal Employment Laws.